# [18F]MC225-PET in Neurodegenerative Disease

> **NCT05853471** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 30 (estimated)

## Conditions studied

- Neurodegenerative Diseases
- Alzheimer Disease
- Parkinson Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** [18F]MC225

## Key facts

- **NCT ID:** NCT05853471
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05853471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05853471, "[18F]MC225-PET in Neurodegenerative Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05853471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*